Cargando…
Co-delivery nanocarriers targeting folate receptor and encapsulating 2-deoxyglucose and α-tocopheryl succinate enhance anti-tumor effect in vivo
A combination administration of chemical agents was highlighted to treat tumors. Recently, tumor cell has been found to be different from normal cell in metabolic manner. Most of cancer cells prefer aerobic glycolysis to mitochondrial oxidative phosphorylation (OXPHOS) to satisfy energy and biomass...
Autores principales: | Lei, Xiaoying, Li, Ke, Liu, Yan, Wang, Zhen Yu, Ruan, Ban Jun, Wang, Li, Xiang, An, Wu, Daocheng, Lu, Zifan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557622/ https://www.ncbi.nlm.nih.gov/pubmed/28848348 http://dx.doi.org/10.2147/IJN.S135849 |
Ejemplares similares
-
Biological fate and interaction with cytochromes P450 of the nanocarrier material, d-α-tocopheryl polyethylene glycol 1000 succinate
por: Ren, Tianming, et al.
Publicado: (2022) -
Selective cancer cell killing by α-tocopheryl succinate
por: Neuzil, J, et al.
Publicado: (2001) -
An α-tocopheryl succinate enzyme-based nanoassembly for cancer imaging and therapy
por: Lee, Song Yi, et al.
Publicado: (2018) -
Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction
por: Zhang, Shouwen, et al.
Publicado: (2018) -
Design and Development of D‒α‒Tocopheryl Polyethylene Glycol Succinate‒block‒Poly(ε-Caprolactone) (TPGS−b−PCL) Nanocarriers for Solubilization and Controlled Release of Paclitaxel
por: Yusuf, Osman, et al.
Publicado: (2021)